ANTHEM BIOSCIENCES
Back to Balance Sheet
|
ANTHEM BIOSCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹55 Cr | ₹250 Cr | ₹226 Cr | ₹5.55 Cr | ₹11 Cr |
What is the latest Contingent Liabilities ratio of ANTHEM BIOSCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹250 Cr |
| Mar2023 | ₹226 Cr |
| Mar2022 | ₹5.55 Cr |
| Mar2021 | ₹11 Cr |
How is Contingent Liabilities of ANTHEM BIOSCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | -78.13 | |
| Mar2024 | ₹250 Cr | 10.68 | |
| Mar2023 | ₹226 Cr | 3,974.99 | |
| Mar2022 | ₹5.55 Cr | -50.02 | |
| Mar2021 | ₹11 Cr | - | |
Compare Contingent Liabilities of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹43,384.6 Cr | -0.6% | 1.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | -0.6% |
1.3% |
|
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses